EUCTR2006-000379-14-IE进行中（未招募）不适用
A double-blind randomised placebo controlled feeding study to establish the effect of a probiotic strain on the course of Clostridium difficile carriage in humans.
Alimentary Health Ltd0 个研究点目标入组 100 人开始时间: 2006年2月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To be considered eligible for enrolment into the study, subjects must
- •1.Be greater than 50 years of age,
- •2.Be in generally good health as determined by the investigator
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects will be excluded from the study if they meet any of the below criteria;
- •1.Are less than 50 years of age
- •2.Have a significant acute or chronic coexisting illness (cardiovascular, gastrointestinal, immunological) or a condition which contraindicates, in the investigators judgement, entry to the study.
- •3.Prior gastrointestinal surgery (apart from appendicectomy and hernia repair) or recent unexplained bleeding which, in the Investigator’s judgment, contraindicates participation in the study.
- •4.Having a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results.
- •5.Individuals who, in the opinion of the investigator, are considered to be poor clinical attendees or unlikely for any reason to be able to comply with the trial.
- •6.Patients may not be receiving treatment involving experimental drugs.
- •7.If the patient has been in a recent experimental trial, must be not less than 30 days prior to this study.
- •8.Have a malignant disease or any concomitant end-stage organ disease, which, in the Investigator’s judgment, contraindicates participation in the study.
研究者
相似试验
已完成
不适用
A feasibility study of octreotide infusion during liver transplantPerioperative bleeding, liver transplantSurgeryISRCTN17573492niversity College London30
已完成
不适用
A double-blind randomised placebo controlled dose escalating phase Ib/IIa study to evaluate the safety and immunogenicity of live attenuated rotavirus vaccine 116E in healthy non-malnourished infants eight to 20 weeks of ageSevere rotavirus diarrhoeaInfections and InfestationsViral and other specified intestinal infectionsISRCTN57452882Bharat Biotech International Ltd (India)540
已完成
不适用
DRIVE - Desmopressin for procedures or radiological interventionsISRCTN12845429HS Blood and Transplant40
已完成
不适用
A randomised double blinded placebo controlled study investigating Atopis for the improvement of skin health in subjects with eczemaEczemaSkin - Dermatological conditionsAlternative and Complementary Medicine - Herbal remediesatopic dermatitisACTRN12615000920594Decima Health Ltd60
已完成
2 期
Clinical and physiological evaluation of a Chinese herbal medicine for constipation-predominant Irritable Bowel Syndrome (C-IBS Trial).Constipation-predominant Irritable Bowel SyndromeAlternative and Complementary Medicine - Herbal remediesACTRN12609000558224niversity of Western Sydney160